| J06BA02 |
Immunoglobulins, normal human, for intravascular adm. |
IMMUNOVENIN-INTACT 5% IgG |
Solution for infusion |
50 mg/ml - 5 ml |
mg |
10 |
БУЛ БИО-НЦЗПБ ЕООД, България |
1 |
mg |
128.54 |
0.05142 |
128.54 |
100% |
|
Съгласно РУ |
НСР-9817/21.07.2016 |
02.09.2016. |
|
Активен |
1318 |
| J06BB01 |
Anti-D (rh) immunoglobulin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J06BB01 |
Anti-D (rh) immunoglobulin |
HYPERRHO S/D FULL DOSE |
Solution for injection |
300 |
mcg |
1 |
Химимпорт Фарма АД, България |
1 |
mcg |
157.94 |
0.52647 |
157.94 |
100% |
|
Съгласно РУ |
; НСР-9436/01.06.2016 |
02.07.2016 |
08.09.2012 |
Заличен |
3163 |
| J06BB04 |
Human hepatitis B immunoglobulin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J06BB04 |
Hepatitis B immunoglobulin |
Hepatect CP 50 IU/ml solutionfor infusion - флакон 10 ml x 1 |
Solution for infusion |
50 IU/ml - 10 ml |
IU |
1 |
Biotest Pharma GmbH, Германия |
1 |
IU |
412.16 |
0.80633 |
403.17 |
100% |
|
Съгласно РУ |
№ 145/ 28.01.2011; КЦРР-428/19.04.2012 г. |
10.05.2012 |
08.09.2012 |
Активен |
1197 |
| J06BB04 |
Hepatitis B immunoglobulin |
Hepatect CP 50 IU/ml solutionfor infusion - флакон 2 ml x 1 |
Solution for infusion |
50 IU/ml - 2 ml |
IU |
1 |
Biotest Pharma GmbH, Германия |
1 |
IU |
83.23 |
0.80633 |
80.63 |
100% |
|
Съгласно РУ |
№ 145/ 28.01.2011; КЦРР-433/19.04.2012 г. |
10.05.2012 |
08.09.2012 |
Активен |
1172 |
| J06BB04 |
Hepatitis B immunoglobulin |
Hepatect CP 50 IU/ml solutionfor infusion - флакон 40 ml x 1 |
Solution for infusion |
50 IU/ml - 40 ml |
IU |
1 |
Biotest Pharma GmbH, Германия |
1 |
IU |
1612.66 |
0.80633 |
1612.66 |
100% |
|
Съгласно РУ |
№ 145/ 28.01.2011; КЦРР-428/19.04.2012 г. |
10.05.2012 |
08.09.2012 |
Активен |
1198 |
| J07AG01 |
Haemophilus tipe b conjugate vaccine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07AG01 |
Hemophilus Influenzae B, Purified Antigen Conjugated |
Hiberix |
Powder and solvent for solution for injection |
Haemophilus influenzae type B polysaccharide – 10 μg, conjugated to 30 μg tetanus toxoid |
mg |
1 |
ГлаксоСмитКлайн ЕООД, България |
|
- |
23.36 |
- |
23.36 |
100% |
|
Съгласно РУ |
КЦРР-888/28.06.2012 г.; КЦРР-2939/20.03.2013 |
26.04.2013 |
08.09.2012 |
Заличен |
1281 |
| J07AJ52 |
Diphtheria, Tetanus and Pertussis (acellular, component) vaccine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07AJ52 |
pertussis, purified antigen, combinations with toxoids |
Infanrix |
Suspension for injection |
Diphtheria toxoid ≥ 30 IU / Filamentous haemagglutinin 25 μg / Pertussis toxoid 25 μg / Tetanus toxoid ≥ 40 IU / Pertactin 8 μg |
mg |
1 |
GlaxoSmithKline Biologicals S.A., Белгия |
|
- |
22.91 |
- |
22.91 |
100% |
|
Съгласно РУ |
КЦРР-2476/27.02.2013. |
21.03.2013 |
08.09.2012 |
Заличен |
130 |
| J07AJ52 |
Diphtheria, Tetanus, Pertussis (acellular component) Vaccine (adsorbed, reduced antigen(s) content) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07AJ52 |
pertussis, purified antigen, combinations with toxoids |
ADACEL susp. inj 0,5ml 1 vial x 1 |
Suspension for injection |
0.5 |
ml |
1 |
Sanofi Pasteur S.A., Франция |
1 |
dose |
30.6 |
30.6 |
30.6 |
100% |
|
Съгласно РУ |
№ 151/ 14.03.2011; КЦРР-2314/20.02.2013 г. |
11.04.2013 |
08.09.2012 |
Активен |
1753 |
| J07AL02 |
Pneumococcal saccharide conjugated vaccine, absorbed |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07AL02 |
Pneumococcus, purified polysaccharides antigen |
Prevenar |
Suspension for injection |
pneumococcal polysaccharide serotype 4 - 2 mcg; pneumococcal polysaccharide serotype 6B - 4 mcg; pneumococcal polysaccharide serotype 9V - 2 mcg; pneumococcal polysaccharide serotype 14 - 2 mcg; pneumococcal oligosaccharide serotype 18c - 2 mcg; pneumococ |
mg |
1 |
Pfizer Limited, Обединено Кралство |
|
- |
96.61 |
- |
96.61 |
100% |
|
Съгласно РУ |
№ 255/ 04.11.2011; КЦPP-1460/02.10.2012 г.; КЦPP-970/16.07.2012 г.; НСР-619/23.07.2013; НСР-3412/30.04.2014 |
02.06.2014 |
08.09.2012 |
Заличен |
2009 |
| J07AL02 |
Pneumococcus, purified polysaccharides antigen |
Prevenar |
Suspension for injection |
pneumococcal polysaccharide serotype 4 - 2 mcg; pneumococcal polysaccharide serotype 6B - 4 mcg; pneumococcal polysaccharide serotype 9V - 2 mcg; pneumococcal polysaccharide serotype 14 - 2 mcg; pneumococcal oligosaccharide serotype 18c - 2 mcg; pneumococ |
mg |
1 |
Pfizer Limited, Обединено Кралство |
|
- |
96.61 |
- |
96.61 |
100% |
|
Съгласно РУ |
№ 255/ 04.11.2011; КЦPP-1460/02.10.2012 г.; КЦPP-970/16.07.2012 г.; НСР-619/23.07.2013; НСР-3412/30.04.2014 |
02.06.2014 |
08.09.2012 |
Заличен |
2009 |
| J07AL02 |
Pneumococcal saccharide conjugated vaccine, absorbed |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07AL02 |
Pneumococcus, purified polysaccharides antigen conjugated |
Prevenar 13 |
Suspension for injection |
0.5 |
ml |
1 pre-fylled syringe |
Pfizer Limited, Обединено Кралство |
0.5 |
mg |
106.13 |
106.13 |
106.13 |
100% |
|
Z23.8 |
КЦРР-2795/20.03.2013; НСР-2500/24.01.2014; НСР-628/23.07.2013 и КП-46/21.05.2014; НСР-7253/21.10.2015. |
16.11.2015 |
|
Заличен |
2862 |
| J07AL52 |
Pneumococcal polysaccharide conjugate vaccine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07AL52 |
Pneumococcus, purified polysaccharides antigen conjugated |
SYNFLORIX |
Suspension for injection |
0.5 ml |
|
1 pre-filled syringe + 1 needle |
GlaxoSmithKline Biologicals S.A., Белгия |
1 |
dose |
76.84 |
76.84 |
76.84 |
100% |
|
Съгласно РУ |
№ 25/03.08.2009; № 89/17.06.2010; НСР-1281/25.09.2013; НСР-3842/16.06.2014 |
16.07.2014 |
08.09.2012 |
Активен |
2958 |
| J07BB02 |
Influenza vaccine (split virion, inactivated) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07BB02 |
influenza, inactivated, split virus or surface antigen |
FLUARIX |
Suspension for injection |
15 mcg haemagglutinin |
mg |
1 pre-filled syringe 0.5 ml |
ГлаксоСмитКлайн ЕООД, България |
1 |
dose |
8.8 |
8.8 |
8.8 |
100% |
|
Съгласно РУ |
№ 121/ 09.12.2010; КЦРР-2462/27.02.2013 г. |
21.03.2013 |
08.09.2012 |
Активен |
1690 |
| J07BB02 |
Influenza vaccine (split virion, inactivated) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J07BB02 |
influenza, inactivated, split virus or surface antigen |
VAXIGRIP |
Suspension for injection |
|
|
1 pre-filled syringe 0,5 ml with attached needle |
Sanofi Pasteur S.A., Франция |
1 |
dose |
10.12 |
10.12 |
10.12 |
100% |
|
Съгласно РУ |
НСР-4242/30.07.2014; НСР-9783/14.07.2016 |
42584 |
|
Заличен |
1926 |
| J07BC01 |
Hepatit B antigen, purified |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|